近日,来自长庚纪念医院的研究者们在J Clin Invest.杂志上发表了题为“miR-181b targets semaphorin 3A to mediate TGF-β–induced endothelial-mesenchymal transition related to atrial fibrillation”的文章,该研究提供了转化生长因子-β通过miR-181b/Sema3A/LIMK/p-cofilin信号诱导的EndMT与心房纤维化之间的机制联系。阻断miR-181b和增加Sema3A是房颤治疗干预的潜在策略。
Ying-Ju Lai et al. miR-181b targets semaphorin 3A to mediate TGF-β–induced endothelial-mesenchymal transition related to atrial fibrillation. J Clin Invest. 2022 Jul 1;132(13):e142548. doi: 10.1172/JCI142548.